DERMAPHARM HOLDING SE (DMP.DE) Stock Fundamental Analysis
FRA:DMP - Deutsche Boerse Ag - DE000A2GS5D8 - Common Stock - Currency: EUR
Overall DMP gets a fundamental rating of 5 out of 10. We evaluated DMP against 50 industry peers in the Pharmaceuticals industry. DMP has a medium profitability rating, but doesn't score so well on its financial health evaluation. DMP is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year DMP was profitable.
DMP had a positive operating cash flow in the past year.
DMP had positive earnings in each of the past 5 years.
In the past 5 years DMP always reported a positive cash flow from operatings.
1.2 Ratios
DMP's Return On Assets of 4.90% is in line compared to the rest of the industry. DMP outperforms 50.00% of its industry peers.
Looking at the Return On Equity, with a value of 16.22%, DMP is in the better half of the industry, outperforming 68.00% of the companies in the same industry.
DMP has a Return On Invested Capital (7.14%) which is comparable to the rest of the industry.
DMP had an Average Return On Invested Capital over the past 3 years of 9.78%. This is below the industry average of 14.77%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.9% | ||
| ROE | 16.22% | ||
| ROIC | 7.14% |
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
1.3 Margins
DMP has a Profit Margin (8.74%) which is in line with its industry peers.
DMP's Profit Margin has declined in the last couple of years.
DMP has a Operating Margin (17.82%) which is in line with its industry peers.
In the last couple of years the Operating Margin of DMP has grown nicely.
DMP's Gross Margin of 64.76% is on the low side compared to the rest of the industry. DMP is outperformed by 60.00% of its industry peers.
DMP's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.82% | ||
| PM (TTM) | 8.74% | ||
| GM | 64.76% |
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
2. Health
2.1 Basic Checks
DMP has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, DMP has about the same amount of shares outstanding.
The number of shares outstanding for DMP remains at a similar level compared to 5 years ago.
Compared to 1 year ago, DMP has a worse debt to assets ratio.
2.2 Solvency
DMP has an Altman-Z score of 2.15. This is not the best score and indicates that DMP is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.15, DMP perfoms like the industry average, outperforming 44.00% of the companies in the same industry.
DMP has a debt to FCF ratio of 7.58. This is a slightly negative value and a sign of low solvency as DMP would need 7.58 years to pay back of all of its debts.
DMP's Debt to FCF ratio of 7.58 is in line compared to the rest of the industry. DMP outperforms 42.00% of its industry peers.
DMP has a Debt/Equity ratio of 1.43. This is a high value indicating a heavy dependency on external financing.
DMP has a worse Debt to Equity ratio (1.43) than 72.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.43 | ||
| Debt/FCF | 7.58 | ||
| Altman-Z | 2.15 |
ROIC/WACC1.19
WACC6.02%
2.3 Liquidity
DMP has a Current Ratio of 2.05. This indicates that DMP is financially healthy and has no problem in meeting its short term obligations.
DMP has a better Current ratio (2.05) than 76.00% of its industry peers.
A Quick Ratio of 0.91 indicates that DMP may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.91, DMP is in line with its industry, outperforming 42.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.05 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 83.06% over the past year.
Measured over the past years, DMP shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.07% on average per year.
The Revenue has been growing slightly by 6.24% in the past year.
DMP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.00% yearly.
EPS 1Y (TTM)83.06%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%-23.48%
Revenue 1Y (TTM)6.24%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%1.24%
3.2 Future
Based on estimates for the next years, DMP will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.11% on average per year.
Based on estimates for the next years, DMP will show a small growth in Revenue. The Revenue will grow by 2.63% on average per year.
EPS Next Y14.57%
EPS Next 2Y12.79%
EPS Next 3Y12.29%
EPS Next 5Y13.11%
Revenue Next Year0.58%
Revenue Next 2Y2.35%
Revenue Next 3Y2.31%
Revenue Next 5Y2.63%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 17.86, DMP is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of DMP is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 27.41. DMP is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 13.18, the valuation of DMP can be described as correct.
68.00% of the companies in the same industry are more expensive than DMP, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.19, DMP is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.86 | ||
| Fwd PE | 13.18 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DMP is valued a bit cheaper than 70.00% of the companies in the same industry.
DMP's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. DMP is cheaper than 76.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.07 | ||
| EV/EBITDA | 9.12 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as DMP's earnings are expected to grow with 12.29% in the coming years.
PEG (NY)1.23
PEG (5Y)2.21
EPS Next 2Y12.79%
EPS Next 3Y12.29%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.57%, DMP has a reasonable but not impressive dividend return.
DMP's Dividend Yield is a higher than the industry average which is at 3.00.
Compared to an average S&P500 Dividend Yield of 2.35, DMP has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.57% |
5.2 History
The dividend of DMP has a limited annual growth rate of 2.71%.
Dividend Growth(5Y)2.71%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
DMP pays out 45.74% of its income as dividend. This is a bit on the high side, but may be sustainable.
DMP's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP45.74%
EPS Next 2Y12.79%
EPS Next 3Y12.29%
FRA:DMP (7/14/2025, 5:29:23 PM)
34.3
+0.05 (+0.15%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners14.73%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.85B
Analysts80
Price Target46.31 (35.01%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.57% |
Yearly Dividend0.88
Dividend Growth(5Y)2.71%
DP45.74%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.37%
PT rev (3m)-6.39%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.9%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.86 | ||
| Fwd PE | 13.18 | ||
| P/S | 1.56 | ||
| P/FCF | 14.07 | ||
| P/OCF | 10.7 | ||
| P/B | 2.89 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.12 |
EPS(TTM)1.92
EY5.6%
EPS(NY)2.6
Fwd EY7.59%
FCF(TTM)2.44
FCFY7.11%
OCF(TTM)3.2
OCFY9.34%
SpS22
BVpS11.86
TBVpS-8.21
PEG (NY)1.23
PEG (5Y)2.21
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.9% | ||
| ROE | 16.22% | ||
| ROCE | 11.69% | ||
| ROIC | 7.14% | ||
| ROICexc | 7.64% | ||
| ROICexgc | 21.24% | ||
| OM | 17.82% | ||
| PM (TTM) | 8.74% | ||
| GM | 64.76% | ||
| FCFM | 11.08% |
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
ROICexc(3y)10.97%
ROICexc(5y)11.73%
ROICexgc(3y)29.64%
ROICexgc(5y)29.05%
ROCE(3y)16.03%
ROCE(5y)16.96%
ROICexcg growth 3Y-9.69%
ROICexcg growth 5Y2.94%
ROICexc growth 3Y-20.13%
ROICexc growth 5Y-1%
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
F-Score7
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.43 | ||
| Debt/FCF | 7.58 | ||
| Debt/EBITDA | 3.07 | ||
| Cap/Depr | 47.38% | ||
| Cap/Sales | 3.48% | ||
| Interest Coverage | 3.84 | ||
| Cash Conversion | 57.88% | ||
| Profit Quality | 126.76% | ||
| Current Ratio | 2.05 | ||
| Quick Ratio | 0.91 | ||
| Altman-Z | 2.15 |
F-Score7
WACC6.02%
ROIC/WACC1.19
Cap/Depr(3y)41.99%
Cap/Depr(5y)70.86%
Cap/Sales(3y)3.57%
Cap/Sales(5y)4.47%
Profit Quality(3y)204.39%
Profit Quality(5y)161.92%
High Growth Momentum
Growth
EPS 1Y (TTM)83.06%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%-23.48%
EPS Next Y14.57%
EPS Next 2Y12.79%
EPS Next 3Y12.29%
EPS Next 5Y13.11%
Revenue 1Y (TTM)6.24%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%1.24%
Revenue Next Year0.58%
Revenue Next 2Y2.35%
Revenue Next 3Y2.31%
Revenue Next 5Y2.63%
EBIT growth 1Y28.45%
EBIT growth 3Y-8.31%
EBIT growth 5Y13.3%
EBIT Next Year57.91%
EBIT Next 3Y19.98%
EBIT Next 5Y6.79%
FCF growth 1Y-54.33%
FCF growth 3Y-4.81%
FCF growth 5Y24.67%
OCF growth 1Y-46.56%
OCF growth 3Y-7%
OCF growth 5Y14.89%